The US Food and Drug Administration has approved a new drug for the treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.
The US Food and Drug Administration has approved a new drug for the treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.
The US Food and Drug Administration has approved a new drug for the treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.
Following the success of 3 clinical trials, the US Food and Drug Administration granted approval to a once-monthly, self-injectable preventive treatment for adults with migraine.
Following the success of 3 clinical trials, the US Food and Drug Administration granted approval to a once-monthly, self-injectable preventive treatment for adults with migraine.
Following the success of 3 clinical trials, the US Food and Drug Administration granted approval to a once-monthly, self-injectable preventive treatment for adults with migraine.
The US Food and Drug Administration has granted approval to the first non-opioid treatment option for the management of withdrawal symptoms in adults who abruptly discontinue opioids.
The US Food and Drug Administration has granted approval to the first non-opioid treatment option for the management of withdrawal symptoms in adults who abruptly discontinue opioids.
